share_log

4: Statement of changes in beneficial ownership of securities-10% Owner Nirland Ltd

4: Statement of changes in beneficial ownership of securities-10% Owner Nirland Ltd

4:持股变动声明-股东 Nirland Ltd
美股SEC公告 ·  10/02 17:05

Moomoo AI 已提取核心信息

Nirland Ltd, a shareholder in Conduit Pharmaceuticals (CDT.US), has engaged in a series of stock disposals from September 30, 2024, to October 2, 2024. The transactions involved the sale of a total of 2,600,000 shares of common stock at prices ranging from $0.1028 to $0.12 per share. The total market value of the disposed shares amounted to approximately $297,644.36. Following these transactions, Nirland Ltd's direct holdings in Conduit Pharmaceuticals decreased to 9,900,000 shares. The sales were executed as open market or private sales and are currently in progress.
Nirland Ltd, a shareholder in Conduit Pharmaceuticals (CDT.US), has engaged in a series of stock disposals from September 30, 2024, to October 2, 2024. The transactions involved the sale of a total of 2,600,000 shares of common stock at prices ranging from $0.1028 to $0.12 per share. The total market value of the disposed shares amounted to approximately $297,644.36. Following these transactions, Nirland Ltd's direct holdings in Conduit Pharmaceuticals decreased to 9,900,000 shares. The sales were executed as open market or private sales and are currently in progress.
Nirland有限公司是Conduit Pharmaceuticals(CDt.US)的股东,自2024年9月30日至2024年10月2日,进行了一系列股票处置。 这些交易涉及以0.1028美元至0.12美元不等的价格出售共计260万股普通股。 处置股份的总市值约为297,644.36美元。 在这些交易之后,Nirland有限公司在Conduit Pharmaceuticals的直接持股减少至990万股。 这些销售是作为公开市场或私人销售执行的,目前正在进行中。
Nirland有限公司是Conduit Pharmaceuticals(CDt.US)的股东,自2024年9月30日至2024年10月2日,进行了一系列股票处置。 这些交易涉及以0.1028美元至0.12美元不等的价格出售共计260万股普通股。 处置股份的总市值约为297,644.36美元。 在这些交易之后,Nirland有限公司在Conduit Pharmaceuticals的直接持股减少至990万股。 这些销售是作为公开市场或私人销售执行的,目前正在进行中。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息